The green light from the EMA, the European Medicines Agency, to the Pfizer vaccine for children between 12 and 15 years is just around the corner. As of June, adolescents will also be able to be vaccinated in Europe, as has been the case for a few weeks in the United States thanks to the green light from the FDA, but what about children? The latest information that arrives refers precisely to the Pfizer vaccine that would begin to be supplied to children between 6 months and 11 years from the beginning of 2022. Pfizer’s vaccine for children between 6 months and 11 years will arrive in 2022. Covid-19 for the little ones, between 6 months and 11 years old, seems to be getting closer and closer. To date, trials have been underway for other subcategories, between 6 months and 5 years and between 5 and 11 years, but the US giant responsible for the vaccine, Pfizer, explained that the date could be early 2022. By the end of the year, the results of the Comirnaty experiment will be available (this is the commercial name of the Pfizer product developed with the German Biontech) between 6 months and 11 years. “If safety and immunogenicity are confirmed – explains the company – we hope to receive authorization for the vaccination of these younger children in early 2022”. We talk about that here. Meanwhile, it will start with older children to protect one of the groups that in recent months has seen infection rates rise the most, although without significant clinical consequences in the vast majority of cases.The debate around the vaccination of adolescents In the last few hours, however, a very important debate has emerged about the vaccination of young people in industrialized countries. Andrew Pollard, director of the Oxford Vaccine Group and one of the coordinators of the Astrazeneca vaccine trials, said in fact that »vaccinating the young before the poor is morally wrong.« The expert explained how, while in countries in In development, high-risk groups have not yet been vaccinated, or have been covered in a minimal percentage, other countries have already started with 12-year-olds: «The ultimate goal of a global vaccination program in a pandemic is to prevent people die .. I have worked in Nepal and Bangladesh, and my colleagues face terrible situations. It seems to me completely morally wrong that this could happen at a time when many countries are vaccinating ever younger populations whose risk is very, very low. Children have a very close to zero risk of serious illness or death. ”Will we have to get vaccinated every year? Albert Bourla, president and CEO of Pfizer, also addressed the issue of the possible third dose, for which studies have already begun In Britain: ‘Continued vaccination beyond 2021 is critical as Covid-19 continues to spread rapidly across Europe and the world. We are working to understand whether, like seasonal flu, annual vaccination can provide the longest-lasting protection. “
Pfizer's vaccine for children could arrive in early 2022
To swim with sharks! This is how entrepreneurs float in the face of inflation
The most successful entrepreneur, and the one who can swim and fall in love with sharks, is the one who is willing to learn from every moment of his process, points out Luis Arandia.
#Between the lines | COVID-19. The sixth wave is coming and a (new) variant...
It is not possible to declare when the sixth wave will arrive in Mexico, but now, more than ever, it is urgent that virological surveillance be maintained, points out Jonathán Torres.
In the new reality, brands must establish messages of closeness
The diffusion of modifications to the organizational culture in the face of a new scenario will be successful if it is underpinned by transparent, close and reliable communication, considers Mario Maraboto.
Covid-19: The end of the pandemic is in sight, says the WHO
Tedros Adhanom Ghebreyesus highlighted that last week the number of weekly deaths fell to its lowest level since March 2020.
COVID: United States authorizes Moderna and Pfizer/BioNTech vaccine boosters
The FDA asked vaccine manufacturers to adapt injections to the two subvariants responsible for the increase in infections worldwide.





